Causal association between Helicobacter pylori infection and Sjogren's syndrome: a bidirectional Mendelian randomization analysis

被引:1
作者
Cui, Dinglu [1 ]
An, Rongxian [1 ]
Li, Lei [1 ]
Jiang, Long [1 ]
Jiang, Chunshan [2 ]
Jin, Jingchun [1 ]
机构
[1] Yanbian Univ Hosp, Dept Rheumatol, 1327 Juzi St, Yanji 133000, Peoples R China
[2] Yanbian Univ Hosp, 1327 Juzi St, Yanji 133000, Peoples R China
基金
中国国家自然科学基金;
关键词
Mendelian randomization; Helicobacter pylori infection; Sjogren's syndrome; Causal inference; SEROPREVALENCE; SEROLOGY;
D O I
10.1186/s12879-024-09678-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background The results of observational studies indicate a potential link between Helicobacter pylori infection and Sjogren's syndrome (SS), but the causal relationship between them remains unknown. This study applied Mendelian randomization (MR) to evaluate this relationship. Method Genome-wide association study (GWAS) summary statistics on H. pylori infection [sample size=8735 (EBI, https://gwas.mrcieu.ac.uk/)] and SS [sample size=368,028 (cases=2495, controls=365533) (FinnGen, https://r9.finngen.fi/)] were analyzed. We used bidirectional MR to evaluate the association between H. pylori infection and SS and identify causation. The major MR analysis method was inverse-variance weighted (IVW) MR, supplemented by MR-Egger and weighted median approaches. In addition, the stability and reliability of the results were tested using the retention method, heterogeneity test, and horizontal gene pleiotropy test. Results Evidence of the impact of H. pylori infection on SS risk was found in the IVW results [odds ratio (OR)=1.6705; 95% confidence interval (CI)=1.0966 to 2.5446; P=0.0168]. Evidence of the impact of SS on H. pylori infection risk was also found (OR=1.0158; 95% CI=1.0033 to 1.0285; P=0.0128). Conclusion The results of MR analysis support a causal association between H. pylori infection and SS and indicate that SS can lead to a greater risk of H. pylori infection. Our research will support the development of novel approaches for continued H. pylori and SS-related research and therapy that consider the genetic relationship between H. pylori infection and SS.
引用
收藏
页数:9
相关论文
共 44 条
  • [1] Aragona P, 1999, J RHEUMATOL, V26, P1306
  • [2] A new model for classification of disease manifestations in primary Sjogren's syndrome: Evaluation in a retrospective long-term study
    Asmussen, K
    Andersen, V
    Bendixen, G
    Schiodt, M
    Oxholm, P
    [J]. JOURNAL OF INTERNAL MEDICINE, 1996, 239 (06) : 475 - 482
  • [3] Mendelian Randomization
    Birney, Ewan
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2022, 12 (04):
  • [4] Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]
  • [5] Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator
    Bowden, Jack
    Smith, George Davey
    Haycock, Philip C.
    Burgess, Stephen
    [J]. GENETIC EPIDEMIOLOGY, 2016, 40 (04) : 304 - 314
  • [6] Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
    Bowden, Jack
    Smith, George Davey
    Burgess, Stephen
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 (02) : 512 - 525
  • [7] Sjogren syndrome
    Brito-Zeron, Pilar
    Baldini, Chiara
    Bootsma, Hendrika
    Bowman, Simon J.
    Jonsson, Roland
    Mariette, Xavier
    Sivils, Kathy
    Theander, Elke
    Tzioufas, Athanasios
    Ramos-Casals, Manuel
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2016, 2
  • [8] Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors
    Burgess, Stephen
    Scott, Robert A.
    Timpson, Nicholas J.
    Smith, George Davey
    Thompson, Simon G.
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2015, 30 (07) : 543 - 552
  • [9] Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
    Burgess, Stephen
    Butterworth, Adam
    Thompson, Simon G.
    [J]. GENETIC EPIDEMIOLOGY, 2013, 37 (07) : 658 - 665
  • [10] Caporali R, 2003, CLIN EXP RHEUMATOL, V21, P266